Status:
COMPLETED
Topical Budesonide Treatment for Eosinophilic Esophagitis (EoE)
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborating Sponsors:
AstraZeneca
Conditions:
Eosinophilic Esophagitis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to conduct a clinical trial of two formulations of budesonide (nebulized/swallowed versus viscous/swallowed) in patients with EoE to determine if medication contact time a...
Eligibility Criteria
Inclusion
- New diagnosis of eosinophilic esophagitis (per 2007 consensus guidelines)
Exclusion
- Age \< 18
- Inability to read or understand English
- Pregnant or nursing women
- Previous allergic reactions to steroid medications
- Current use of systemic steroids
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2011
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00961233
Start Date
October 1 2009
End Date
November 1 2011
Last Update
November 6 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of North Carolina
Chapel Hill, North Carolina, United States, 27599